Henrik Keränen

Henrik Keränen

Johnson & Johnson Co. - New Jersey / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4396579
-
person_outline Henrik Keränen's MOST POPULAR ARTICLES
1-) Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges Structure 22 (8), 1120-1139, 2014
2-) Acylguanidine beta secretase 1 inhibitors: A combined experimental and free energy perturbation study Journal of chemical theory and computation 13 (3), 1439-1453, 2017
3-) Predicting binding free energies of PDE2 inhibitors. The difficulties of protein conformation Scientific reports 8 (1), 4883, 2018
4-) Computational identification of uncharacterized cruzain binding sitesJD Durrant, H Keränen, BA Wilson, JA McCammonPLoS neglected tropical diseases 4 (5), e676, 2010682010
5-) Predicting binding free energies of PDE2 inhibitors. The difficulties of protein conformationL Pérez-Benito, H Keränen, H van Vlijmen, G TresadernScientific reports 8 (1), 4883, 2018592018